Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success

Virology Journal

Volumn 6, Issue , 2009, Pages

  McIntyre, Glen J ^a   Yu, Yi Hsin ^a   Tran, Anna ^a   Jaramillo, Angel B ^a   Arndt, Allison J ^a   Millington, Michelle L ^a   Boyd, Maureen P ^a   Elliott, Fiona A ^a   Shen, Sylvie W ^a   Murray, John M ^b,c   Applegate, Tanya L ^a  

^a JOHNSON AND JOHNSON   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; SHORT HAIRPIN RNA; VIRUS RNA; SMALL INTERFERING RNA;

ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DISEASE COURSE; GENE CASSETTE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE REPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL MODEL; TREATMENT OUTCOME; VIRAL GENE THERAPY; VIRUS GENE; VIRUS MUTANT; VIRUS REPLICATION; COMPUTER SIMULATION; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; METHODOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

COMPUTER SIMULATION; GENE THERAPY; HIV INFECTIONS; HIV-1; HUMANS; MUTAGENESIS, INSERTIONAL; RNA, SMALL INTERFERING; SEQUENCE DELETION;

EID: 72849106754     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-184     Document Type: Article

References (58)

1. Ribo-gnome: the big world of small RNAs. PD Zamore B Haley, Science 2005 309 1519 1524 10.1126/science.1111444 16141061
2. Unlocking the potential of the human genome with RNA interference. GJ Hannon JJ Rossi, Nature 2004 431 371 378 10.1038/nature02870 15372045
3. Therapeutic potential of RNA interference. M Stevenson, N Engl J Med 2004 351 1772 1777 10.1056/NEJMra045004 15496626
4. Optimal design and validation of antiviral siRNA for targeting HIV-1. Naito Nohtomi Onogi Uenishi Ui-Tei Saigo Takebe, Retrovirology 2007 4 80 17996047 10.1186/1742-4690-4-80
5. Silencing of HIV-1 with RNA interference: a multiple shRNA approach. O ter Brake P Konstantinova M Ceylan B Berkhout, Mol Ther 2006 14 883 892 10.1016/j.ymthe.2006.07.007 16959541
6. -96 shRNAs designed for maximal coverage of HIV-1 variants. G Mcintyre J Groneman Y Yu A Jaramillo S Shen T Applegate, Retrovirology 2009 6 55 19497094 10.1186/1742-4690-6-55
7. Human immunodeficiency virus type 1 escapes from RNA interference- mediated inhibition. AT Das TR Brummelkamp Westerhout M Vink M Madiredjo R Bernards B Berkhout, Journal of Virology 2004 78 2601 2605 14963165 10.1128/JVI.78.5.2601-2605.2004 (Pubitemid 38228957)
8. Human immunodeficiency virus type 1 escape from RNA interference. Boden Pusch Lee Tucker Ramratnam, Journal of Virology 2003 77 11531 11535 14557638 10.1128/JVI.77.21.11531-11535.2003 (Pubitemid 37271651)
9. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. EM Westerhout M Ooms M Vink AT Das B Berkhout, Nucleic Acids Res 2005 33 796 804 15687388 10.1093/nar/gki220 (Pubitemid 40361009)
10. Effective Suppression of Human Immunodeficiency Virus Type 1 through a Combination of Short- or Long-Hairpin RNAs Targeting Essential Sequences for Retroviral Integration. Nishitsuji, Journal of Virology 2006 80 7658 7666 16840344 10.1128/JVI.00078-06 (Pubitemid 44092586)
11. Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs. R Sabariegos M Gimenez-Barcons N Tapia B Clotet MA Martinez, J Virol 2006 80 571 577 16378959 10.1128/JVI.80.2.571-577. 2006 (Pubitemid 43062869)
12. A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs. O Ter brake B Berkhout, Journal of RNAi and Gene Silencing 2005 1 56 65
13. Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region. JA Wilson CD Richardson, J Virol 2005 79 7050 7058 15890944 10.1128/JVI.79.11.7050-7058.2005 (Pubitemid 40677336)
14. Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. JN Leonard DV Schaffer, J Virol 2005 79 1645 1654 15650190 10.1128/JVI.79.3.1645-1654.2005 (Pubitemid 40459111)
15. Simultaneous inhibition of GSK3alpha and GSK3beta using hairpin siRNA expression vectors. JY Yu J Taylor SL DeRuiter AB Vojtek DL Turner, Mol Ther 2003 7 228 236 10.1016/S1525-0016(02)00037-0 12597911
16. Generation of single and double knockdowns in polarized epithelial cells by retrovirus-mediated RNA interference. S Schuck A Manninen M Honsho J Fullekrug K Simons, Proc Natl Acad Sci USA 2004 101 4912 4917 15051873 10.1073/pnas.0401285101 (Pubitemid 38469177)
17. Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. MT Lee GA Coburn MO McClure BR Cullen, J Virol 2003 77 11964 11972 14581533 10.1128/JVI.77.22.11964-11972.2003 (Pubitemid 37339850)
18. HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector. J Anderson R Akkina, AIDS Res Ther 2005 2 1 15813990 10.1186/1742-6405-2-1 (Pubitemid 44848757)
19. Amplification of RNAi - targeting HLA mRNAs. S Gonzalez D Castanotto H Li S Olivares MC Jensen SJ Forman JJ Rossi LJ Cooper, Mol Ther 2005 11 811 818 10.1016/j.ymthe.2004.12.023 15851019
20. The Efficacy of Generating Three Independent Anti-HIV-1 siRNAs from a Single U6 RNA Pol III-Expressed Long Hairpin RNA. Saayman Barichievy Capovilla Morris Arbuthnot Weinberg Bowyer, PLoS ONE 2008 3 2602 18596982 10.1371/journal.pone.0002602
21. Design of extended short hairpin RNAs for HIV-1 inhibition. Liu Haasnoot Berkhout, Nucleic Acids Research 2008 35 5683 5693 10.1093/nar/gkm596
22. Expression of Long Anti-HIV-1 Hairpin RNAs for the Generation of Multiple siRNAs: Advantages and Limitations. Sano Li Nakanishi Rossi, Mol Ther 2008 16 170 177 10.1038/sj.mt.6300298 17726454
23. A versatile approach to multiple gene RNA interference using microRNA-based short hairpin RNAs. X Zhu LA Santat MS Chang J Liu JR Zavzavadjian EA Wall C Kivork MI Simon ID Fraser, BMC Mol Biol 2007 8 98 17971228 10.1186/1471-2199-8-98
24. A novel approach for the construction of multiple shRNA expression vectors. Gou Weng Wang Wang Zhang Gao Chen Wang Liu, J Gene Med 2007 9 751 763 10.1002/jgm.1080 17657830
25. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. Henry Vanderwegen Metselaar Tilanus Scholte Vanderlaan, Mol Ther 2006 14 485 493 10.1016/j.ymthe.2006.04.012 16872906
26. Impact of gene-modified T cells on HIV infection dynamics. D von Laer S Hasselmann K Hasselmann, Journal of theoretical biology 2006 238 60 77 10.1016/j.jtbi.2005.05.005 15993899
27. Lentiviruses as gene transfer agents for delivery to non-dividing cells. L Naldini, Curr Opin Biotechnol 1998 9 457 463 10.1016/S0958-1669(98)80029-3 9821272
28. Gene Therapy Progress and Prospects: Development of improved lentiviral and retroviral vectors - design, biosafety, and production. P Sinn S Sauter P Mccray, Gene Ther 2005 12 1089 1098 10.1038/sj.gt.3302570 16003340
29. 'Advanced' generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo. D Bonci A Cittadini M Latronico U Borello J Aycock A Drusco A Innocenzi A Follenzi M Lavitrano M Monti, et al. Gene Ther 2003 10 630 636 10.1038/sj.gt.3301936 12692591
30. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. DA Rubinson CP Dillon AV Kwiatkowski C Sievers L Yang J Kopinja DL Rooney MM Ihrig M McManus FB Gertler, et al. Nat Genet 2003 33 401 406 10.1038/ng1117 12590264
31. Lentiviral delivery of short hairpin RNAs. N Manjunath H Wu S Subramanya P Shankar, Adv Drug Deliv Rev 2009 1 14 19124052
32. Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells. Nishitsuji, Microbes and Infection 2004 6 76 85 10.1016/j.micinf.2003.10.009 (Pubitemid 38114824)
33. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. RA Dickins MT Hemann JT Zilfou DR Simpson I Ibarra GJ Hannon SW Lowe, Nat Genet 2005 37 1163 1165 10.1038/ng1105-1163 16254559
34. Gene transfer in humans using a conditionally replicating lentiviral vector. BL Levine LM Humeau J Boyer RR MacGregor T Rebello X Lu GK Binder V Slepushkin F Lemiale JR Mascola, et al. Proc Natl Acad Sci USA 2006 103 17372 17377 17090675 10.1073/pnas.0608138103 (Pubitemid 44788976)
35. Long-Term Inhibition of HIV-1 Infection in Primary Hematopoietic Cells by Lentiviral Vector Delivery of a Triple Combination of Anti-HIV shRNA, Anti-CCR5 Ribozyme, and a Nucleolar-Localizing TAR Decoy. MJ Li JD Kim SL Li JA Zaia JK Yee J Anderson R Akkina JJ Rossi, Mol Ther 2005 12 900 909 10.1016/j.ymthe.2005. 07.524 16115802
36. Strand transfer events during HIV-1 reverse transcription. VP Basu M Song L Gao ST Rigby MN Hanson RA Bambara, Virus Res 2008 134 19 38 10.1016/j.virusres.2007.12.017 18279992
37. Frequency of direct repeat deletion in a human immunodeficiency virus type 1 vector during reverse transcription in human cells. W An A Telesnitsky, Virology 2001 286 475 482 10.1006/viro.2001.1025 11485415
38. A detailed model of reverse transcription and tests of crucial aspects. E Gilboa SW Mitra S Goff D Baltimore, Cell 1979 18 93 100 10.1016/0092-8674(79) 90357-X 509527
39. Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. JM Coffin, J Gen Virol 1979 42 1 26 10.1099/0022-1317-42-1- 1 215703
40. Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. HM Temin, Proc Natl Acad Sci USA 1993 90 6900 6903 7688465 10.1073/pnas.90.15.6900
41. Retroviral recombination rates do not increase linearly with marker distance and are limited by the size of the recombining subpopulation. JA Anderson EH Bowman WS Hu, J Virol 1998 72 1195 1202 9445018
42. HIV-1 genetic recombination: experimental approaches and observations. W An A Telesnitsky, AIDS reviews 2002 4 195 212 12555694
43. Human immunodeficiency virus type 1 genetic recombination is more frequent than that of Moloney murine leukemia virus despite similar template switching rates. A Onafuwa W An N Robson A Telesnitsky, J Virol 2003 77 4577 4587 12663764 10.1128/JVI.77.8.4577-4587.2003 (Pubitemid 36402807)
44. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. LM Mansky HM Temin, J Virol 1995 69 5087 5094 7541846
45. Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition. O Brake K Hooft Y Liu M Centlivre K Jasmijn von Eije B Berkhout, Mol Ther 2008 16 557 564 10.1038/sj.mt.6300382 18180777
46. An Infinitely Expandable Cloning Strategy plus Repeat-Proof PCR for Working with Multiple shRNA. G Mcintyre J Groneman A Tran T Applegate, PLoS ONE 2008 3 3827 19043584 10.1371/journal.pone.0003827
47. Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors. M Paar D Klein B Salmons WH Günzburg M Renner D Portsmouth, BMC Mol Biol 2009 10 8 19203366 10.1186/1471-2199-10-8
48. High rate of recombination throughout the human immunodeficiency virus type 1 genome. AE Jetzt H Yu GJ Klarmann Y Ron BD Preston JP Dougherty, J Virol 2000 74 1234 1240 10627533 10.1128/JVI.74.3.1234-1240.2000 (Pubitemid 30044072)
49. Effect of distance between homologous sequences and 3' homology on the frequency of retroviral reverse transcriptase template switching. KA Delviks VK Pathak, J Virol 1999 73 7923 7932 10482539
50. Effects of varying sequence similarity on the frequency of repeat deletion during reverse transcription of a human immunodeficiency virus type 1 vector. W An A Telesnitsky, J Virol 2002 76 7897 7902 12097604 10.1128/JVI.76.15.7897-7902.2002 (Pubitemid 34761014)
51. Effects of homology length in the repeat region on minus-strand DNA transfer and retroviral replication. Q Dang WS Hu, J Virol 2001 75 809 820 11134294 10.1128/JVI.75.2.809-820.2001 (Pubitemid 32040905)
52. Effects of limiting homology at the site of intermolecular recombinogenic template switching during Moloney murine leukemia virus replication. JK Pfeiffer A Telesnitsky, J Virol 2001 75 11263 11274 11689606 10.1128/JVI.75.23.11263-11274.2001 (Pubitemid 33063216)
53. Homologous recombination in Escherichia coli: dependence on substrate length and homology. P Shen HV Huang, Genetics 1986 112 441 457 3007275
54. Differential effects of base-pair mismatch on intrachromosomal versus extrachromosomal recombination in mouse cells. AS Waldman RM Liskay, Proc Natl Acad Sci USA 1987 84 5340 5344 3037544 10.1073/pnas.84.15.5340
55. Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Liu Haasnoot T Brake Berkhout Konstantinova, Nucleic Acids Research 2008 36 2811 2824 18346971 10.1093/nar/gkn109 (Pubitemid 351737175)
56. Design and cloning strategies for constructing shRNA expression vectors. GJ McIntyre GC Fanning, BMC Biotechnol 2006 6 1 16396676 10.1186/1472-6750-6-1 (Pubitemid 43085336)
57. A simple method of estimating fifty per cent endpoints. LJ Reed H Muench, The American Journal of Hygiene (now Epidemiology) 1938 27 493 497
58. Thymic function in HIV infection. R Hazra C Mackall, Current HIV/AIDS reports 2005 2 24 28 10.1007/s11904-996-0005-2 16091245